Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Class of drugs (Bronchodilators, Antibiotics), End User (Hospital Lab), Technology (Radioimmunoassay, Fluorescence Immunoassay, GCMS) – 2021 to 2026

$3,850.00$5,850.00

Published on: April 1, 2021
Clear
SKU: GMS-1221 Category:

OVERVIEW

The therapeutic drug monitoring market size is expected to surpass USD 2.06 billion by 2026 on account of COVID-19, growing at a CAGR of 6.9 percent over the forecast period. The outbreak of COVID is anticipated to drive the demand for equipment being used in TDM. Researchers have been focusing on testing a variety of potential drugs to find a suitable treatment for COVID-19. To support laboratories with this challenge, players operating in the TDM market are providing controls and calibrators and this might be a major driver for this market.

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Class of drugs (Bronchodilators, Antibiotics), End User (Hospital Lab), Technology (Radioimmunoassay, Fluorescence Immunoassay, GCMS) – 2021 to 2026 1

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Class of drugs (Bronchodilators, Antibiotics), End User (Hospital Lab), Technology (Radioimmunoassay, Fluorescence Immunoassay, GCMS) – 2021 to 2026 2

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Class of drugs (Bronchodilators, Antibiotics), End User (Hospital Lab), Technology (Radioimmunoassay, Fluorescence Immunoassay, GCMS) – 2021 to 2026 3

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Class of drugs (Bronchodilators, Antibiotics), End User (Hospital Lab), Technology (Radioimmunoassay, Fluorescence Immunoassay, GCMS) – 2021 to 2026 4

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Class of drugs (Bronchodilators, Antibiotics), End User (Hospital Lab), Technology (Radioimmunoassay, Fluorescence Immunoassay, GCMS) – 2021 to 2026 5

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Class of drugs (Bronchodilators, Antibiotics), End User (Hospital Lab), Technology (Radioimmunoassay, Fluorescence Immunoassay, GCMS) – 2021 to 2026 6

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Class of drugs (Bronchodilators, Antibiotics), End User (Hospital Lab), Technology (Radioimmunoassay, Fluorescence Immunoassay, GCMS) – 2021 to 2026 7

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Class of drugs (Bronchodilators, Antibiotics), End User (Hospital Lab), Technology (Radioimmunoassay, Fluorescence Immunoassay, GCMS) – 2021 to 2026 8

TABLE OF CONTENT

1 Global Therapeutic Drug Monitoring Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Therapeutic Drug Monitoring Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Therapeutic Drug Monitoring Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Therapeutic Drug Monitoring Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Therapeutic Drug Monitoring Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Therapeutic Drug Monitoring Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Therapeutic Drug Monitoring Market – By Product (Market Size – & million/billion)
8.1 Consumables
8.2 Equipment

9 Global Therapeutic Drug Monitoring Market – By Technology
9.1 Immunoassays
9.2 Colorimetric Immunoassays
9.3 Radioimmunoassays
9.4 Other

10 Global Therapeutic Drug Monitoring Market – By Class of Drug
10.1 Antiepileptic Drugs
10.2 Antiarrhythmic Drugs
10.3 Immunosuppressant Drugs
10.4 Antibiotic Drugs
10.5 Bronchodilator Drugs
10.6 Other

11 Global Therapeutic Drug Monitoring Market – By End-User
11.1 Hospital Laboratories
11.2 Commercial/Private Laboratories
11.3 Other

12 Global Therapeutic Drug Monitoring Market – By Geography (Market Size – &
million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Therapeutic Drug Monitoring Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Therapeutic Drug Monitoring Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Danaher Corporation
14.3 Thermo Fisher Scientific
14.4 Siemens Healthineers
14.5 F. Hoffmann-La Roche
14.6 Abbott Laboratories
14.7 Randox Laboratories
14.8 Sekisui Medical
14.9 Bühlmann Laboratories
14.10 Biomérieux
14.11 Bio-Rad Laboratories
14.12 Company 11 & more

15 Global Therapeutic Drug Monitoring Market – Appendix
15.1 Sources
15.2 Abbreviations